Selected research
Industry Growth & Trends
Global Propranolol Tablet Industry Growth and Trends Forecast to 2032
Market perspective
The global Propranolol Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Propranolol Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Propranolol Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Propranolol Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Propranolol Tablet include AbZ-Pharma GmbH, Apotex, Atnas Pharma, IFET, Intas Pharma, Iqfarma, Nichi-Iko Pharmaceutical, Sawai Seiyaku and Towa Yakuhin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Propranolol Tablet market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Propranolol Tablet market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Propranolol Tablet market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Propranolol Tablet.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Propranolol Tablet market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Propranolol Tablet Market by Company
AbZ-Pharma GmbH
Apotex
Atnas Pharma
IFET
Intas Pharma
Iqfarma
Nichi-Iko Pharmaceutical
Sawai Seiyaku
Towa Yakuhin
Zentiva
Zydus Pharma
Yabang Pharma
Mylan
Novartis
Sanofi
Teva
Propranolol Tablet Segment by Type
60mg
40mg
20mg
Other
Propranolol Tablet Segment by Application
Atrial Fibrillation
Myocardial Infarction
Angina
Other
Propranolol Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propranolol Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Propranolol Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propranolol Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Propranolol Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Propranolol Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 60mg
- 40mg
- 20mg
- Other
Applications
- Atrial Fibrillation
- Myocardial Infarction
- Angina
- Other
Companies covered
- AbZ-Pharma GmbH
- Apotex
- Atnas Pharma
- IFET
- Intas Pharma
- Iqfarma
- Nichi-Iko Pharmaceutical
- Sawai Seiyaku
- Towa Yakuhin
- Zentiva
- Zydus Pharma
- Yabang Pharma
- Mylan
- Novartis
- Sanofi
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Propranolol Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Propranolol Tablet Sales Estimates and Forecasts (2021-2032)
- 1.3 Propranolol Tablet Market by Type
- 1.3.1 60mg
- 1.3.2 40mg
- 1.3.3 20mg
- 1.3.4 Other
- 1.4 Global Propranolol Tablet Market Size by Type
- 1.4.1 Global Propranolol Tablet Market Size Overview by Type (2021-2032)
- 1.4.2 Global Propranolol Tablet Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Propranolol Tablet Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Propranolol Tablet Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Propranolol Tablet Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Propranolol Tablet Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Propranolol Tablet Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Propranolol Tablet Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Propranolol Tablet Industry Trends
- 2.2 Propranolol Tablet Industry Drivers
- 2.3 Propranolol Tablet Industry Opportunities and Challenges
- 2.4 Propranolol Tablet Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Propranolol Tablet Revenue (2021-2026)
- 3.2 Global Top Players by Propranolol Tablet Sales (2021-2026)
- 3.3 Global Top Players by Propranolol Tablet Price (2021-2026)
- 3.4 Global Propranolol Tablet Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Propranolol Tablet Major Company Production Sites & Headquarters
- 3.6 Global Propranolol Tablet Company, Product Type & Application
- 3.7 Global Propranolol Tablet Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Propranolol Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Propranolol Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Propranolol Tablet Tier 1, Tier 2, and Tier 3
4 Propranolol Tablet Regional Status and Outlook
- 4.1 Global Propranolol Tablet Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Propranolol Tablet Historic Market Size by Region
- 4.2.1 Global Propranolol Tablet Sales in Volume by Region (2021-2026)
- 4.2.2 Global Propranolol Tablet Sales in Value by Region (2021-2026)
- 4.2.3 Global Propranolol Tablet Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Propranolol Tablet Forecasted Market Size by Region
- 4.3.1 Global Propranolol Tablet Sales in Volume by Region (2027-2032)
- 4.3.2 Global Propranolol Tablet Sales in Value by Region (2027-2032)
- 4.3.3 Global Propranolol Tablet Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Propranolol Tablet by Application
- 5.1 Propranolol Tablet Market by Application
- 5.1.1 Atrial Fibrillation
- 5.1.2 Myocardial Infarction
- 5.1.3 Angina
- 5.1.4 Other
- 5.2 Global Propranolol Tablet Market Size by Application
- 5.2.1 Global Propranolol Tablet Market Size Overview by Application (2021-2032)
- 5.2.2 Global Propranolol Tablet Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Propranolol Tablet Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Propranolol Tablet Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Propranolol Tablet Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Propranolol Tablet Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Propranolol Tablet Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Propranolol Tablet Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 AbZ-Pharma GmbH
- 6.1.1 AbZ-Pharma GmbH Company Information
- 6.1.2 AbZ-Pharma GmbH Business Overview
- 6.1.3 AbZ-Pharma GmbH Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 AbZ-Pharma GmbH Propranolol Tablet Product Portfolio
- 6.1.5 AbZ-Pharma GmbH Recent Developments
- 6.2 Apotex
- 6.2.1 Apotex Company Information
- 6.2.2 Apotex Business Overview
- 6.2.3 Apotex Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Apotex Propranolol Tablet Product Portfolio
- 6.2.5 Apotex Recent Developments
- 6.3 Atnas Pharma
- 6.3.1 Atnas Pharma Company Information
- 6.3.2 Atnas Pharma Business Overview
- 6.3.3 Atnas Pharma Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Atnas Pharma Propranolol Tablet Product Portfolio
- 6.3.5 Atnas Pharma Recent Developments
- 6.4 IFET
- 6.4.1 IFET Company Information
- 6.4.2 IFET Business Overview
- 6.4.3 IFET Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 IFET Propranolol Tablet Product Portfolio
- 6.4.5 IFET Recent Developments
- 6.5 Intas Pharma
- 6.5.1 Intas Pharma Company Information
- 6.5.2 Intas Pharma Business Overview
- 6.5.3 Intas Pharma Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Intas Pharma Propranolol Tablet Product Portfolio
- 6.5.5 Intas Pharma Recent Developments
- 6.6 Iqfarma
- 6.6.1 Iqfarma Company Information
- 6.6.2 Iqfarma Business Overview
- 6.6.3 Iqfarma Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Iqfarma Propranolol Tablet Product Portfolio
- 6.6.5 Iqfarma Recent Developments
- 6.7 Nichi-Iko Pharmaceutical
- 6.7.1 Nichi-Iko Pharmaceutical Company Information
- 6.7.2 Nichi-Iko Pharmaceutical Business Overview
- 6.7.3 Nichi-Iko Pharmaceutical Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Nichi-Iko Pharmaceutical Propranolol Tablet Product Portfolio
- 6.7.5 Nichi-Iko Pharmaceutical Recent Developments
- 6.8 Sawai Seiyaku
- 6.8.1 Sawai Seiyaku Company Information
- 6.8.2 Sawai Seiyaku Business Overview
- 6.8.3 Sawai Seiyaku Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Sawai Seiyaku Propranolol Tablet Product Portfolio
- 6.8.5 Sawai Seiyaku Recent Developments
- 6.9 Towa Yakuhin
- 6.9.1 Towa Yakuhin Company Information
- 6.9.2 Towa Yakuhin Business Overview
- 6.9.3 Towa Yakuhin Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Towa Yakuhin Propranolol Tablet Product Portfolio
- 6.9.5 Towa Yakuhin Recent Developments
- 6.10 Zentiva
- 6.10.1 Zentiva Company Information
- 6.10.2 Zentiva Business Overview
- 6.10.3 Zentiva Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Zentiva Propranolol Tablet Product Portfolio
- 6.10.5 Zentiva Recent Developments
- 6.11 Zydus Pharma
- 6.11.1 Zydus Pharma Company Information
- 6.11.2 Zydus Pharma Business Overview
- 6.11.3 Zydus Pharma Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Zydus Pharma Propranolol Tablet Product Portfolio
- 6.11.5 Zydus Pharma Recent Developments
- 6.12 Yabang Pharma
- 6.12.1 Yabang Pharma Company Information
- 6.12.2 Yabang Pharma Business Overview
- 6.12.3 Yabang Pharma Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Yabang Pharma Propranolol Tablet Product Portfolio
- 6.12.5 Yabang Pharma Recent Developments
- 6.13 Mylan
- 6.13.1 Mylan Company Information
- 6.13.2 Mylan Business Overview
- 6.13.3 Mylan Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Mylan Propranolol Tablet Product Portfolio
- 6.13.5 Mylan Recent Developments
- 6.14 Novartis
- 6.14.1 Novartis Company Information
- 6.14.2 Novartis Business Overview
- 6.14.3 Novartis Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Novartis Propranolol Tablet Product Portfolio
- 6.14.5 Novartis Recent Developments
- 6.15 Sanofi
- 6.15.1 Sanofi Company Information
- 6.15.2 Sanofi Business Overview
- 6.15.3 Sanofi Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Sanofi Propranolol Tablet Product Portfolio
- 6.15.5 Sanofi Recent Developments
- 6.16 Teva
- 6.16.1 Teva Company Information
- 6.16.2 Teva Business Overview
- 6.16.3 Teva Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Teva Propranolol Tablet Product Portfolio
- 6.16.5 Teva Recent Developments
7 North America by Country
- 7.1 North America Propranolol Tablet Sales by Country
- 7.1.1 North America Propranolol Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Propranolol Tablet Sales by Country (2021-2026)
- 7.1.3 North America Propranolol Tablet Sales Forecast by Country (2027-2032)
- 7.2 North America Propranolol Tablet Market Size by Country
- 7.2.1 North America Propranolol Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Propranolol Tablet Market Size by Country (2021-2026)
- 7.2.3 North America Propranolol Tablet Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Propranolol Tablet Sales by Country
- 8.1.1 Europe Propranolol Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Propranolol Tablet Sales by Country (2021-2026)
- 8.1.3 Europe Propranolol Tablet Sales Forecast by Country (2027-2032)
- 8.2 Europe Propranolol Tablet Market Size by Country
- 8.2.1 Europe Propranolol Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Propranolol Tablet Market Size by Country (2021-2026)
- 8.2.3 Europe Propranolol Tablet Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Propranolol Tablet Sales by Country
- 9.1.1 Asia-Pacific Propranolol Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Propranolol Tablet Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Propranolol Tablet Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Propranolol Tablet Market Size by Country
- 9.2.1 Asia-Pacific Propranolol Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Propranolol Tablet Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Propranolol Tablet Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Propranolol Tablet Sales by Country
- 10.1.1 South America Propranolol Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Propranolol Tablet Sales by Country (2021-2026)
- 10.1.3 South America Propranolol Tablet Sales Forecast by Country (2027-2032)
- 10.2 South America Propranolol Tablet Market Size by Country
- 10.2.1 South America Propranolol Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Propranolol Tablet Market Size by Country (2021-2026)
- 10.2.3 South America Propranolol Tablet Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Propranolol Tablet Sales by Country
- 11.1.1 Middle East and Africa Propranolol Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Propranolol Tablet Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Propranolol Tablet Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Propranolol Tablet Market Size by Country
- 11.2.1 Middle East and Africa Propranolol Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Propranolol Tablet Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Propranolol Tablet Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Propranolol Tablet Value Chain Analysis
- 12.1.1 Propranolol Tablet Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Propranolol Tablet Production Mode & Process
- 12.2 Propranolol Tablet Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Propranolol Tablet Distributors
- 12.2.3 Propranolol Tablet Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst